BriaCell Therapeutics Statistics
NASDAQ: BCTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.06-0.105 (-3.32%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BriaCell Therapeutics by the numbers
BriaCell Therapeutics has a market capitalization of $26.7 million based on 8.73M shares outstanding. With trailing EPS of $-6.97, BriaCell Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.9% below its 50-day average and 18.1% below its 200-day average.
Average daily trading volume is 250.81K shares, or about $767,485 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BCTX valuation vs. peer median
| Metric | BCTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $26.72M | $28.67M | -7% |
| Avg. volume | 250.81K | 153.03K | +64% |
Peer median across 8 companies: TELO, NSRX, EDSA, PMN, AYTU, ATHE, RNTX, NNVC.
Valuation
- Market cap
- $26.72M
- EPS (TTM)
- $-6.97
- Shares outstanding
- 8.73M
Price and trading
- Previous close
- 3.17
- Open
- 3.14
- Day range
- 3.02 – 3.20
- 52-week range
- 2.60 – 13.09
- 52-week change
- -61.75%
- Beta
- —
- Volume
- 109.66K
- Average volume
- 250.81K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 10, 2026
Additional statistics
- Market Cap
- 26.72M
- Forward Pe
- -7.85
- Eps
- -6.97
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.09
- Week52 Low
- 2.60
- Avg Volume
- 250.81K
- Shares Outstanding
- 8.73M
- Ma50
- 3.68
- Ma200
- 3.74
- Earnings Date
- Dec 10, 2026
- Pct From52w High
- -76.62%
- Pct From52w Low
- 17.69%